首页> 美国卫生研究院文献>Journal of Genetic Engineering Biotechnology >Construction and sequencing analysis of scFv antibody fragment derived from monoclonal antibody against norfloxacin (Nor155)
【2h】

Construction and sequencing analysis of scFv antibody fragment derived from monoclonal antibody against norfloxacin (Nor155)

机译:抗诺氟沙星(Nor155)单克隆抗体scFv抗体片段的构建和序列分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Norfloxacin belongs to the group of fluoroquinolone antibiotics which has been approved for treatment in animals. However, its residues in animal products can pose adverse side effects to consumer. Therefore, detection of the residue in different food matrices must be concerned. In this study, a single chain variable fragment (scFv) that recognizes norfloxacin antibiotic was constructed. The cDNA was synthesized from total RNA of hybridoma cells against norfloxacin. Genes encoding VH and VL regions of monoclonal antibody against norfloxacin (Nor155) were amplified and size of VH and VL fragments was 402 bp and 363 bp, respectively. The scFv of Nor155 was constructed by an addition of (Gly4Ser)3 as a linker between VH and VL regions and subcloned into pPICZαA, an expression vector of Pichia pastoris. The sequence of scFv Nor155 (GenBank No. ) was confirmed by sequencing analysis. The complementarity determining regions (CDR) I, II, and III of VH and VL were specified by Kabat method. The obtained recombinant plasmid will be useful for production of scFv antibody against norfloxacin in P. pastoris and further engineer scFv antibody against fluoroquinolone antibiotics.
机译:诺氟沙星属于氟喹诺酮类抗生素,已被批准用于动物治疗。但是,其在动物产品中的残留物可能对消费者造成不利的副作用。因此,必须关注不同食品基质中残留物的检测。在这项研究中,构建了识别诺氟沙星抗生素的单链可变片段(scFv)。从抗诺氟沙星的杂交瘤细胞总RNA中合成cDNA。扩增了编码诺氟沙星(Nor155)单克隆抗体VH和VL区的基因,VH和VL片段的大小分别为402 bp和363 bp。通过在VH和VL区之间添加(Gly4Ser)3作为接头构建Nor155的scFv,并将其亚克隆到巴斯德毕赤酵母的表达载体pPICZαA中。通过测序分析确认了scFv Nor155的序列(GenBank No.)。 VH和VL的互补决定区(CDR)I,II和III通过Kabat方法指定。获得的重组质粒将可用于在巴斯德毕赤酵母中产生抗诺氟沙星的scFv抗体,并进一步工程改造抗氟喹诺酮抗生素的scFv抗体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号